Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. - Wikidata - wikimedia - TriplyDB

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.

http://www.wikidata.org/entity/Q33729015

about

Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons"Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles The Clinical Relevance of Long Non-Coding RNAs in Cancer Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases Tumor-derived exosomes in cancer progression and treatment failure The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma Long non-coding RNAs in anti-cancer drug resistance Basic biology and therapeutic implications of lncRNA Liver Diseases and Long Non-Coding RNAs: New Insight and Perspective The roles and implications of exosomes in sarcoma Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging.Noncoding RNA as therapeutic targets for hepatocellular carcinoma.Exosomes in cancer: small particle, big player.Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.Circulating Extracellular RNA Markers of Liver Regeneration.Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1.Long noncoding RNAs in diseases of aging.ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.Extending gene ontology in the context of extracellular RNA and vesicle communication.Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma.BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma Emerging roles for long noncoding RNAs in skeletal biology and disease.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Extracellular vesicles-mediated noncoding RNAs transfer in cancer.Exosomes as mediators of platinum resistance in ovarian cancer.Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer Exosomes: From Garbage Bins to Promising Therapeutic Targets.Long noncoding RNAs in liver cancer: what we know in 2014."Small Talk" in the Innate Immune System via RNA-Containing Extracellular Vesicles.

P2860

Q26747281-B2A98220-5638-49A6-86BA-82ABBA9C5CB0 Q26751346-3CD3A53E-F987-4269-B41A-B47A5B031688 Q26764843-E8510B1A-F9B7-43C4-A1E5-CFDFE5E0F6B5 Q26767257-B161B443-91FE-447B-9D34-3B9E31D8ADC8 Q26767270-C528C16D-43ED-45A7-8207-4514D6EDD5AA Q26777757-155742D5-1A49-4EDD-8B21-52B7151A29ED Q26783960-DCA64350-3AB1-4C0F-B5A5-A61A7B07F8B3 Q26785408-AF58158C-5B46-4D1F-A86C-2A1358DA14CF Q28066407-B7318383-EE57-4893-9FA0-09966A6ECEF5 Q28072366-1E604C00-CFD8-490E-A1FF-3B5C44B47424 Q28080732-A0691127-1CE7-439D-87E8-02DEE86A9B77 Q28084106-2E436DA2-A258-4308-87F9-49B3FA833832 Q30249353-B7AD96D7-334A-4EC3-9874-9D75BF9A34CB Q33713586-CB234165-D74D-47AE-9D62-A055428BF125 Q33779396-1B02D574-0D7A-4D69-BE1F-27CE005A3D09 Q33875858-00365473-58C4-485E-BC9E-A8FD44ECD31A Q34982521-B20D38D7-A93B-41F3-98E9-8C467F45A9FC Q35592207-4D9F4AA8-CABC-4EF6-B59A-551EEA3D7E55 Q35834473-AE740372-448F-4212-A0DA-515DF6111E5C Q35901823-57483591-2D03-40D1-B3A2-BEAC79225967 Q35954464-B7D1EFCE-6ED1-4FDB-A86F-C8361ADC9DE3 Q36077655-C802FEEC-60AD-4BD7-A1A6-78B12254AE87 Q36095147-C289A5FF-1D90-4DB7-B86F-D1ACEBA9292A Q36422024-EB70CC1F-21F3-4BBE-8888-51D9CB6A1BE8 Q36738916-1D89B9EC-6C23-42DF-8368-A9D671ADE3BD Q36793712-63C16BBC-5A95-4652-9057-096730D832D8 Q36935052-AE733583-D142-41C2-946E-D4A87761C4ED Q37165105-E2E289C9-957B-4AD8-9BF1-BEE7E3F11642 Q37252275-A589A09D-D132-46B0-86BE-ACF5183E5782 Q37302281-36068983-0F8E-41AC-9A13-A4D60898CE48 Q37416360-7393F4E0-D1D1-46BC-AE3C-B62EC010030F Q37604659-E4F7A3A5-97A7-4A27-97CA-C85682B94B5D Q37635533-CA89B92F-AE1D-4F4A-8E4B-D87B15F39371 Q37654423-1F9021F7-E1FE-4644-B012-D57B0DD771A1 Q37663393-6FF436C5-FE28-4663-9987-B45F143DE6A8 Q37707018-F22AE0FF-1B28-48D9-87D9-DDF8D2E1AE76 Q37709184-EFD193E7-E1E3-4514-A709-160DBA511314 Q37729108-D7291A27-C9FE-4058-AC62-F897E0BD3532 Q38241983-F584ABEC-60BA-4019-B6C2-C8AB00140526 Q38268636-6F373324-7D2B-4C94-A393-CE4AA957D0C4

P2860

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.

http://www.wikidata.org/entity/Q33729015

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@ast

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@en

type

label

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@ast

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@en

prefLabel

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@ast

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@en

P1433

Q33729015-02D5C379-D53A-441B-B710-FE2EC52EB7C4

P1476

Q33729015-54D80A8A-1892-4FD2-A1F2-982FCB28EB22

P2093

Q33729015-190C0F00-B6EC-48AF-8256-E2BE3CA2E684

Q33729015-200807D9-A356-43E2-BC12-1C048FCA83DB

Q33729015-34AFEC34-3167-4783-B5E8-7FD8FC44B844

Q33729015-40566555-8B96-424E-A3FE-6DA31208C65E

Q33729015-7A2A3A47-E8E2-416E-A8B8-FE80258E598C

P2860

Q33729015-0DF96BC8-A696-4258-B0AC-8EEAE69F8F46

Q33729015-14AB853A-5AC8-4495-BDDA-DF4F7BC0EAE2

Q33729015-18C05E04-9065-403C-8FF3-54EC46B510A5

Q33729015-1A329E96-0DCF-46C7-A276-7FFF900F933E

Q33729015-1F533684-BC70-4C4C-8317-149634CE4A9E

Q33729015-20E4048C-0A73-4C43-8CB4-EA836C58540D

Q33729015-2DBEC7EA-6F73-496F-B422-88E0B56CB79B

Q33729015-3550C01A-5913-47CB-97B4-7D1E85EB0B8F

Q33729015-57925D5E-39B4-4BBF-A423-4F5C17DF4B70

Q33729015-5E4E8205-E530-4218-A7D5-6E96199DEAA6

P304

Q33729015-2C319381-8BE4-4AF6-A9E9-5568FD0330C2

P31

Q33729015-3FE479A3-71C6-4F0C-B477-601443971E4D

P356

Q33729015-B45E5A1F-E328-40E3-B40C-93E14271F2BC

P478

Q33729015-D55EF585-736C-44B2-AE95-D1CA26406D4E

P577

Q33729015-A35ABCE6-F0DD-4477-9827-1366BE40DE48

P5875

Q33729015-24FF5ABD-29E9-45AF-B088-B76B08E9326B

P698

Q33729015-753CAD98-7191-4BD2-97A8-CFB20A97DB60

P921

Q33729015-86DAC278-084F-48D0-8BB0-4D57C3639B57

P932

Q33729015-D941D2F0-2980-4D3C-B76E-18CC8FCC358D

P356

J.FOB.2014.04.007

P1433

P1476

Extracellular vesicle-mediated ...... n human hepatocellular cancer.

@en

P2093

Hiroaki Haga

http://www.w3.org/2001/XMLSchema#string

Irene K Yan

http://www.w3.org/2001/XMLSchema#string

Kenji Takahashi

http://www.w3.org/2001/XMLSchema#string

Takayuki Kogure

http://www.w3.org/2001/XMLSchema#string

Tushar Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

Sorafenib in advanced hepatocellular carcinoma

TGFbeta in Cancer

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Polycomb complexes repress developmental regulators in murine embryonic stem cells

Membrane vesicles as conveyors of immune responses

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.

P304

458-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FOB.2014.04.007

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262195932

http://www.w3.org/2001/XMLSchema#string

P698

24918061

http://www.w3.org/2001/XMLSchema#string

P921

P932

4050189

http://www.w3.org/2001/XMLSchema#string